David Larsen
Stock Analyst at BTIG
(2.00)
# 3,051
Out of 5,182 analysts
109
Total ratings
35.16%
Success rate
-5.23%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Reiterates: Buy | $55 | $46.03 | +19.49% | 7 | Mar 19, 2026 | |
| LFMD LifeMD | Reiterates: Buy | $10 | $3.91 | +155.75% | 5 | Mar 10, 2026 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $3.30 | +112.12% | 2 | Mar 9, 2026 | |
| MDLN Medline | Reiterates: Buy | $55 | $47.22 | +16.48% | 2 | Mar 9, 2026 | |
| PGNY Progyny | Maintains: Buy | $35 → $30 | $16.98 | +76.68% | 5 | Mar 5, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $8 | $2.53 | +216.21% | 9 | Feb 25, 2026 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | n/a | $21.15 | - | 4 | Feb 24, 2026 | |
| HQY HealthEquity | Maintains: Buy | $130 → $110 | $79.91 | +37.65% | 6 | Feb 17, 2026 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $37 → $40 | $24.75 | +61.62% | 4 | Feb 17, 2026 | |
| DOCS Doximity | Maintains: Buy | $80 → $50 | $22.66 | +120.65% | 3 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $6.46 | +70.28% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $28.88 | +38.50% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.95 | - | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $2.36 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $21.63 | - | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $158.45 | +114.58% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $9.64 | +55.60% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.06 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $171.99 | +51.17% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $0.99 | +606.00% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.58 | +1,107.10% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.01 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.01 | +52.11% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.22 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $5.55 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $214.18 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $864.57 | -81.49% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $75.99 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $78.09 | +8.85% | 3 | Feb 9, 2018 |
BrightSpring Health Services
Mar 19, 2026
Reiterates: Buy
Price Target: $55
Current: $46.03
Upside: +19.49%
LifeMD
Mar 10, 2026
Reiterates: Buy
Price Target: $10
Current: $3.91
Upside: +155.75%
The Oncology Institute
Mar 9, 2026
Reiterates: Buy
Price Target: $7
Current: $3.30
Upside: +112.12%
Medline
Mar 9, 2026
Reiterates: Buy
Price Target: $55
Current: $47.22
Upside: +16.48%
Progyny
Mar 5, 2026
Maintains: Buy
Price Target: $35 → $30
Current: $16.98
Upside: +76.68%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $2.53
Upside: +216.21%
Hims & Hers Health
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $21.15
Upside: -
HealthEquity
Feb 17, 2026
Maintains: Buy
Price Target: $130 → $110
Current: $79.91
Upside: +37.65%
Consensus Cloud Solutions
Feb 17, 2026
Maintains: Buy
Price Target: $37 → $40
Current: $24.75
Upside: +61.62%
Doximity
Feb 6, 2026
Maintains: Buy
Price Target: $80 → $50
Current: $22.66
Upside: +120.65%
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $6.46
Upside: +70.28%
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $28.88
Upside: +38.50%
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $12.95
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.36
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $21.63
Upside: -
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $158.45
Upside: +114.58%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $9.64
Upside: +55.60%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.06
Upside: -
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $171.99
Upside: +51.17%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $0.99
Upside: +606.00%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.58
Upside: +1,107.10%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $35.01
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.01
Upside: +52.11%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $5.22
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $5.55
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $214.18
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $864.57
Upside: -81.49%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $75.99
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $78.09
Upside: +8.85%